Here, we showed that ERK-mediated Drp1 phosphorylation is necessary for resisting chemotherapeutic cytotoxicity and reported for the first time that this mediation was associated with extracellular HMGB1 released from dying tumor cells. Here, DNM1L is linked to neoplasm.